<DOC>
	<DOCNO>NCT00610883</DOCNO>
	<brief_summary>Non-Hodgin 's lymphoma curable 76 % patient . In nonlymphoblastic lymphmas , cancer may return average 3 month begin treatment lymphoblastic lymphoma , 6 month . To aggressively treat cancer study use effective drug three part : - Induction end day 19 - Consolidation end day 38 42 - Maintenance may include 6 cycle</brief_summary>
	<brief_title>LSA4 Protocol Treatment Advanced Pediatric Adolescent Non-Hodgkins Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<criteria>NonHodgkin 's Lymphoma stag III , IV , IVA 1 . T cell lymphoma , primary site irrespective LDH level 2. large cell lymphoma , primary site irrespective LDH level 3 . B cell lymphoma , primary site initial LDH le 500 B cell lymphoma , primary site initial LDH le 500 initial CNS bone involvement</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>